Newsroom

In 2025, the Antibiogo application is seeing wide deployment, extending beyond MSF field operations. After being adopted by all MSF laboratories in 2024, the tool has also been integrated by local health authorities in several countries: Burkina Faso, Comoros, Guinea, Liberia, Mali, Central African Republic, Democratic Republic of the Congo, and Benin. This expansion marks a new era for Antibiogo: scaling up.

At the same time, the project team continued efforts to reach the highest level of quality standards, culminating in obtaining ISO 13485 certification. This unprecedented level of requirement for an NGO project reflects the excellence of the management practices implemented for this medical device project, for which MSF Foundation is the legal manufacturer.